A Pilot Study of Short-Duration Hyperbaric Oxygen Therapy to Improve HbA1c, Leukocyte, and Serum Creatinine in Patients with Diabetic Foot Ulcer Wagner 3-4

Hendry Irawan, I Nyoman Semadi, I Gde Raka Widiana, Hendry Irawan, I Nyoman Semadi, I Gde Raka Widiana

Abstract

Objective: To evaluate the short-duration hyperbaric oxygen therapy (HBOT) can improve HbA1c levels, leukocyte count, and serum creatinine levels in patients with diabetic foot ulcer (DFU) Wagner 3-4.

Methods: Blood samples from all DFU patients at Sanglah General Hospital, Denpasar, were taken for HbA1c, leukocyte, and serum creatinine test before debridement procedure, and the patients were then grouped into either standard therapy or standard therapy with HBOT for 10 sessions (combination therapy). At the end of therapy, all blood tests were resumed.

Results: Each group consisted of 15 patients. Results of laboratory analysis before and after treatment were significant regarding decrease of HbA1c levels in standard therapy (10.98 ± 2.37 % to 9.70 ± 2.46 %; p = 0.006), HbA1c levels in combination therapy (9.42 ± 1.96 % to 7.07 ± 1.16 %; p < 0.001), and leukocyte count in combination therapy (13.97 ± 6.24 x 103 cells/μL to 8.84 ± 2.88 x 103 cells/μL; p = 0.009). The HbA1c levels at the end of therapy were significantly different between groups (p = 0.001). Serum creatinine level was decreased only in combination therapy but it was not significant. The effect size of all variables was larger in the combination therapy, but it was not significant (p > 0.05).

Conclusion: The use of short-duration HBOT on DFU reduces HbA1c levels, leukocyte count, and serum creatinine levels better than standard therapy alone. This protocol would save time and effort in future HBOT implementation. This trial is registered with ClinicalTrials.gov Identifier: NCT03615755.

References

    1. Kementerian Kesehatan Republik Indonesia. Diabetes Melitus Penyebab Kematian Nomor 6 di Dunia: Kemenkes Tawarkan Solusi Cerdik Melalui Posbind. 2013, .
    1. World Health Organization. Global status report on noncommunicable diseases 2010. Switzerland: WHO Press,, World Health; 2011.
    1. Révision de la IVe Conférence de consensus en thérapeutique anti-infectieuse de la Société de pathologie infectieuse de langue française (SPILF). Médecine et Maladies Infectieuses. 2001;31(5):265–266. doi: 10.1016/S0399-077X(01)00230-X.
    1. World Health Organization. Global Report on Diabetes. Switzerland: WHO Press; 2016.
    1. Frykberg R. G., Zgonis T., Armstrong D. G., et al. Diabetic foot disorders. A clinical practice guideline (2006 revision) Journal of Foot and Ankle Surgery. 2006;45(5):S1–S66. doi: 10.1016/s1067-2516(07)60001-5.
    1. Wounds International. International Best Practice Guidelines: Wound Management in Diabetic Foot Ulcers. London: Wounds International A division of Schofield Healthcare Media Limited Enterprise House; 2013.
    1. Kessler L., Bilbault P., Ortéga F., et al. Hyperbaric oxygenation accelerates the healing rate of nonischemic chronic diabetic foot ulcers a prospective randomized study. Diabetes Care. 2003;26(8):2378–2382. doi: 10.2337/diacare.26.8.2378.
    1. Waniczek D., Kozowicz A., Muc-Wierzgoń M., Kokot T., Świętochowska E., Nowakowska-Zajdel E. Adjunct Methods of the Standard Diabetic Foot Ulceration Therapy. Evidence-Based Complementary and Alternative Medicine. 2013;2013:12. doi: 10.1155/2013/243568.243568
    1. Jeffcoate W. J., Game F. L. Evidence for the Use of biological therapies in ulcers of the foot in diabetes. BioDrugs. 2014;28(1):1–6. doi: 10.1007/s40259-013-0052-3.
    1. Flood M. S. Hyperbaric Oxygen Therapy for diabetic Foot Ulcers. The Journal of Lancaster General Hospital. 2007:140–145.
    1. Bhutani S., Vishwanath G. Hyperbaric oxygen and wound healing. Indian Journal of Plastic Surgery. 2012;45(2):316–324. doi: 10.4103/0970-0358.101309.
    1. Karadurmus N., Sahin M., Tasci C., et al. Potential benefits of hyperbaric oxygen therapy on atherosclerosis and glycaemic control in patients with diabetic foot. Endokrynologia Polska. 2010;61(3):275–279.
    1. Aydin F., Kaya A., Karapinar L., et al. IGF-1 increases with hyperbaric oxygen therapy and promotes wound healing in diabetic foot ulcers. Journal of Diabetes Research. 2013;2013567834
    1. El-Kader S. M. A., Ashmawy E. M. Impact of Different Therapeutic Modalities on Healing of Diabetic Foot Ulcers. Eur J Gen Med. 2015;12:319–325.
    1. Gupta S. K., Sharma A. K. Effects of hyperbaric oxygen therapy on haematological and biochemical parameters. Ind J Aerospace Med. 2000;44:1–5.
    1. Al-Waili N. S., Butler G. J., Beale J., et al. Influences of hyperbaric oxygen on blood pressure, heart rate and blood glucose levels in patients with diabetes mellitus and hypertension. Archives of Medical Research. 2006;37(8):991–997. doi: 10.1016/j.arcmed.2006.05.009.
    1. Nwafor T. S., Collins N. Managing low blood glucose levels in patients undergoing hyperbaric oxygen therapy. Ostomy Wound Management. 2014;60(4):12–15.
    1. Wilkinson D., Chapman I. M., Heilbronn L. K. Hyperbaric oxygen therapy improves peripheral insulin sensitivity in humans. Diabetic Medicine. 2012;29(8):986–989. doi: 10.1111/j.1464-5491.2012.03587.x.
    1. Irawan H., Kartika Terapi Oksigen Hiperbarik sebagai Terapi Adjuvan Kaki Diabetik. Cermin Dunia Kedokteran-245. 2016;43:782–785.
    1. Thom S. R. Hyperbaric oxygen: its mechanisms and efficacy. Plastic and Reconstructive Surgery. 2011;127(1):131S–141S. doi: 10.1097/prs.0b013e3181fbe2bf.
    1. Klein K. C., Guha S. C. Cutaneous wound healing: Current concepts and advances in wound care. Indian Journal of Plastic Surgery. 2014;47(3):303–317.
    1. Mathieu D. Handbook on Hyperbaric Medicine. Berlin, Germany: Springer; 2006.
    1. Wibowo A. Oksigen Hiperbarik: Terapi Percepatan Penyembuhan Luka. JuKe Unila. 2015;5:124–128.
    1. Uzun G., Mutluoglu M., Uz Ö. Hyperbaric oxygen therapy in diabetic patients - comments on the paper by Karadurmus et al. Endokrynologia Polska. 2011;62:286–287.
    1. Fife C. E., Buyukcakir C., Otto G., Sheffield P., Love T., Warriner R., III Factors influencing the outcome of lower-extremity diabetic ulcers treated with hyperbaric oxygen therapy. Wound Repair and Regeneration. 2007;15(3):322–331. doi: 10.1111/j.1524-475X.2007.00234.x.
    1. Kevin T. Pengaruh Terapi Oksigen Hiperbarik Terhadap eGFR berdasarkan Formula MDRD pada pasien Luka Kaki Diabetik (skripsi) Surabaya, Indonesia: Universitas Katolik Widya Mandala; 2015.
    1. Ayvaz S., Aksu B., Kanter M., et al. Preventive effects of hyperbaric oxygen treatment on glycerol-induced myoglobinuric acute renal failure in rats. Journal of Molecular Histology. 2012;43(2):161–170. doi: 10.1007/s10735-012-9391-5.
    1. Migita H., Yoshitake S., Tange Y., Choijookhuu N., Hishikawa Y. Hyperbaric oxygen therapy suppresses apoptosis and promotes renal tubular regeneration after renal ischemia/reperfusion injury in rats. Nephro-Urology Monthly. 2016;8(1)e34421
    1. Solmazgul E., Uzun G., Cermik H., Atasoyu E. M., Aydinoz S., Yildiz S. Hyperbaric oxygen therapy attenuates renal ischemia/reperfusion injury in rats. Urologia Internationalis. 2007;78(1):82–85. doi: 10.1159/000096941.
    1. Rubinstein I., Abassi Z., Milman F., et al. Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney. Nephrology Dialysis Transplantation . 2009;24(2):428–436. doi: 10.1093/ndt/gfn511.
    1. Berkovitch M., Tsadik R., Kozer E., Abu-Kishk I. The effect of hyperbaric oxygen therapy on kidneys in a rat model. The Scientific World Journal. 2014;2014105069
    1. Singh V. P., Bali A., Singh N., Jaggi A. S. Advanced glycation end products and diabetic complications. Korean Journal of Physiology & Pharmacology. 2014;18(1):1–14. doi: 10.4196/kjpp.2014.18.1.1.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner